How much does it cost to receive breaking news feed?
Sarepta Therapeutics Positive Meeting with FDA
The Fly 5/15/15
Top Stock Mutual Fund New Buys: CyberArk Software
BY JULIE MAK, INVESTOR'S BUSINESS DAILY
05/05/2015 06:28 PM ET
a good buy here .
GSK shingles vaccine shows benefits across all age groupsReuters
GSK shingles vaccine shows benefits across all age groups
Goldman Sachs analysts said in a report on Tuesday that efficacy across age groups gives HZ/su a meaningful edge over Zostavax, and GSK's product had the potential to achieve peak sales of around 1 billionpounds ($1.5 billion) a year.